0001683168-20-001272.txt : 20200424 0001683168-20-001272.hdr.sgml : 20200424 20200424161555 ACCESSION NUMBER: 0001683168-20-001272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200423 FILED AS OF DATE: 20200424 DATE AS OF CHANGE: 20200424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dal Poggetto John CENTRAL INDEX KEY: 0001791040 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33216 FILM NUMBER: 20815137 MAIL ADDRESS: STREET 1: 1129 N. MCDOWELL BLVD CITY: PETALUMA STATE: CA ZIP: 94954 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001367083 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680423298 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1129 N. MCDOWELL BLVD. CITY: PETALUMA STATE: CA ZIP: 94954 BUSINESS PHONE: 707-283-0550 MAIL ADDRESS: STREET 1: 1129 N. MCDOWELL BLVD. CITY: PETALUMA STATE: CA ZIP: 94954 FORMER COMPANY: FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc. DATE OF NAME CHANGE: 20060622 4 1 ownership.xml X0306 4 2020-04-23 0 0001367083 Sonoma Pharmaceuticals, Inc. SNOA 0001791040 Dal Poggetto John C/O SONOMA PHARMACEUTICALS, INC. 1129 N. MCDOWELL BLVD PETALUMA CA 94954 0 1 0 0 Chief Financial Officer Common Stock, $0.0001 par value 2020-04-23 4 A 0 3086 A 3201 D The shares were granted pursuant to the mutual separation and release agreement dated April 14, 2020. /s/ John Dal Poggetto 2020-04-24